FDA inspection

William Beaumont Hospital IRB: FDA inspection ending Jun 27, 2002

FDA inspection 223054 · Voluntary Action Indicated (VAI) · Royal Oak, MI

Key facts

Inspection ID 223054
Firm William Beaumont Hospital IRB
FEI number 1823222
Address 3601 W 13 Mile Rd
City Royal Oak
State MI
ZIP 48073-6712
Fiscal year 2002
Inspection end date Jun 27, 2002
Classification Voluntary Action Indicated (VAI)
Project area Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices|Human Cellular, Tissue and Gene Therapies|Product Evaluation: Med Devices
Product type Biologics, Devices, Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections